Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
Athira Pharma Inc (NASDAQ: ATHA) closed the day trading at $0.32 down -3.05% from the previous closing price of $0.33. In other words, the price has decreased by -$3.05 from its previous closing price. On the day, 1.66 million shares were traded. ATHA stock price reached its highest trading level at $0.3499 during the session, while it also had its lowest trading level at $0.317.
Ratios:
For a better understanding of ATHA, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.18 and its Current Ratio is at 4.18. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Mizuho on September 19, 2024, Downgraded its rating to Neutral and sets its target price to $0.50 from $5 previously.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 02 ’25 when San Martin Javier sold 10,826 shares for $0.56 per share. The transaction valued at 6,083 led to the insider holds 35,841 shares of the business.
Litton Mark James sold 25,107 shares of ATHA for $14,108 on Jan 02 ’25. The President and CEO now owns 242,591 shares after completing the transaction at $0.56 per share. On Jan 02 ’25, another insider, CHURCH KEVIN, who serves as the CHIEF SCIENTIFIC OFFICER of the company, sold 8,510 shares for $0.56 each. As a result, the insider received 4,782 and left with 130,761 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ATHA now has a Market Capitalization of 12415483 and an Enterprise Value of -37642504.
Stock Price History:
The Beta on a monthly basis for ATHA is 2.99, which has changed by -0.8786259 over the last 52 weeks, in comparison to a change of 0.07903516 over the same period for the S&P500. Over the past 52 weeks, ATHA has reached a high of $3.67, while it has fallen to a 52-week low of $0.30. The 50-Day Moving Average of the stock is -33.27%, while the 200-Day Moving Average is calculated to be -76.39%.
Shares Statistics:
Over the past 3-months, ATHA traded about 220.40K shares per day on average, while over the past 10 days, ATHA traded about 307350 shares per day. A total of 39.04M shares are outstanding, with a floating share count of 35.70M. Insiders hold about 8.55% of the company’s shares, while institutions hold 46.13% stake in the company. Shares short for ATHA as of 1740700800 were 886263 with a Short Ratio of 4.02, compared to 1738281600 on 949474. Therefore, it implies a Short% of Shares Outstanding of 886263 and a Short% of Float of 3.2099999999999995.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
